Vialwirebiotech, curated
May 18, 2026, 3:31 AM
May 15, 2026
- 5:15 PMLizzy Lawrence / STAT News:STAT+: FDA drug center head Tracy Beth Høeg leaves as agency faces leadership vacuum
- 4:00 PMFT — Pharmaceuticals:‘Botox’ boom shows no sign of sagging as inflation hits luxury sector
- 1:41 PMEd Silverman / STAT News:STAT+: Takeda will pay $13.6 million to settle allegations it paid kickbacks to doctors
- 1:31 PMNicole DeFeudis / Endpoints News:Amgen expands crackdown on what it says is misuse of 340B program
- 12:07 PMGlobalData Healthcare / Pharmaceutical Technology:ECO 2026: indirect comparison favours Wegovy pill over Foundayo
- 12:00 PMBioWorld:Validity of Actelion patent hinges on temperature
- 12:00 PMBioWorld:EU reaches Critical Medicines Act pact to tackle drug shortages
- 12:00 PMBioWorld:Sonomind raises €20M for ultrasound neuromodulation technology
- 11:58 AMJonathan Gardner / BioPharma Dive:FDA hold puts Aardvark Prader-Willi drug in limbo
- 11:47 AMSydney Halleman / BioPharma Dive:Supreme Court preserves access to abortion pill by mail
- 11:36 AMBioPharma Dive staff / BioPharma Dive:Biotech leaders campaign for Pazdur; Takeda to lay off 4,500 workers
- 11:30 AMNicole DeFeudis / Endpoints News:Candel reports prostate cancer drug's long-term data ahead of FDA filing
- 9:17 AMPharmaceutical Executive:<![CDATA[FDA Approves Fasenra for Hypereosinophilic Syndrome]]>
- 9:00 AMBioWorld:Financing at Create Medicines to advance in vivo CAR therapies
- 9:00 AMBioWorld:HCW Biologics’ HCW11-040 prevents bronchopulmonary dysplasia
- 9:00 AMBioWorld:KSI-028 suppresses STING-driven inflammation
- 9:00 AMBioWorld:Camp4 studies CMP-002 in SYNGAP1 haploinsufficient mouse model
- 8:00 AMRoohi Mariam Peter / Labiotech (EU):CAR-T therapy for stiff person syndrome nears approval
- 7:00 AMAlex Hoffman / Endpoints News:Andrea Pfeifer ends 23-year reign at AC Immune; Acadia's top R&D exec announces retirement
- 6:45 AMRyan Cross / Endpoints News:#ASGCT26: A Zillow-like marketplace for abandoned gene therapies goes live
- 6:44 AMSalong Debbarma / Pharmaceutical Technology:Arna Pharma and Slate Run complete JV for new US company
- 6:00 AMBruno Quinney / Drug Discovery World:Collaboration set to develop neuroinflammation therapeutics
- 5:00 AMBruno Quinney / Drug Discovery World:Canadian companies to partner on novel antibody therapies
- 4:42 AMSalong Debbarma / Pharmaceutical Technology:Kyowa Kirin secures FDA approval for Crysvita dosing update
May 14, 2026
- 2:50 PMRyan Cross / Endpoints News:#ASGCT26: Encoded's gene therapy reduced seizures in Dravet syndrome
- 12:09 PMBruno Quinney / Drug Discovery World:Infinitopes appoints CSO to advance immuno-oncology pipeline
- 12:00 PMAnna Brown / Endpoints News:Drugmakers have to go through rigorous tests to get a lower tariff rate
- 10:42 AMENDPOINTS / Endpoints News:Degron, CREATE, TenNor raise capital; Cabaletta posts CAR-T data
- 10:31 AMElizabeth Cairns / Endpoints News:AstraZeneca follows Merck with Phase 3 win in bladder cancer
- 10:10 AMAnna Brown / Endpoints News:MacroGenics sells manufacturing arm; West Pharma discloses cybersecurity attack
- 9:54 AMBruno Quinney / Drug Discovery World:Gene editing technology could treat Hepatitis B
- 9:23 AMPharmaceutical Executive:<![CDATA[FDA Approves Beqalzi for Relapsed or Refractory Mantle Cell Lymphoma, Inqovi in Combination with Venetoclax]]>
- 7:32 AMMax Gelman / Endpoints News:Biogen's anti-tau Alzheimer's drug misses Phase 2 goal, but claims signs of efficacy
- 7:00 AMLei Lei Wu / Endpoints News:Regenxbio hits Duchenne gene therapy milestone, eyes 2027 FDA approval
- 6:31 AMAyisha Sharma / Endpoints News:BeOne’s next-gen BCL2 inhibitor wins FDA approval, taking aim at Venclexta
- 6:24 AMBruno Quinney / Drug Discovery World:MHRA to open Northern Ireland hub to boost life sciences
- 5:00 AMBruno Quinney / Drug Discovery World:UK centre opens to accelerate Parkinson’s treatment research